Completed NCT02466386
This study exists to understand how the medication SPD489 holds up over time after the earliest research stage. Researchers are trying to understand whether the medication SPD489 can improve attention, thinking, or day-to-day functioning.
In United States ADHD Drug i A study involving a medication or substance. From 4 Years to 5 Years
Countries United States
Sponsor Shire
Condition ADHD Completed NCT01552772
This study is completed in the United States. It focuses on schizophrenia.
In United States Schizophrenia Drug From 18 Years to 64 Years
Countries United States
Sponsor Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition Schizophrenia Completed NCT04183400
This summary needs review. Please check the official study record and contact the research team for details.
In United States Addiction Behavioral From 18 Years to 21 Years
Countries United States
Sponsor University of Denver
Condition Addiction Completed NCT02192554
This study is completed in the United States, in France, in Canada, .... It focuses on Mental health.
In United States Mental health Other
Countries United States, France, Canada, ...
Sponsor Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition Mental health Completed NCT06471686
This summary needs review. Please check the official study record and contact the research team for details.
In United States Addiction Drug From 18 Years to 75 Years
Countries United States
Sponsor University of Southern California
Condition Addiction Terminated NCT02813447
This summary needs review. Please check the official study record and contact the research team for details.
In United States Anxiety, Depression Drug Over 40 Years
Countries United States
Sponsor Duke University
Condition Anxiety, Depression Completed NCT00258479
This summary needs review. Please check the official study record and contact the research team for details.
In United States Addiction Behavioral From 16 Years to 40 Years
Countries United States
Sponsor Catherine Martin, MD
Condition Addiction Completed NCT04855760
This summary needs review. Please check the official study record and contact the research team for details.
In United States Depression Drug From 18 Years to 65 Years
Countries United States
Sponsor Relmada Therapeutics, Inc.
Condition Depression Completed NCT03655470
This summary needs review. Please check the official study record and contact the research team for details.
In United States Suicidality Behavioral From 12 Years to 18 Years
Countries United States
Sponsor Brown University
Condition Suicidality Enrolling By Invitation NCT05307432
This summary needs review. Please check the official study record and contact the research team for details.
Remote / online Suicidality Behavioral Over 18 Years
Countries United States
Sponsor University of Pennsylvania
Condition Suicidality Completed NCT03227991
This summary needs review. Please check the official study record and contact the research team for details.
In United States Suicidality Behavioral Over 18 Years
Countries United States
Sponsor New York State Psychiatric Institute
Condition Suicidality Completed NCT00516386
This summary needs review. Please check the official study record and contact the research team for details.
In United States Eating disorders Drug From 12 Years to 18 Years
Countries United States
Sponsor Massachusetts General Hospital
Condition Eating disorders